Realizing effectiveness across continents with hydroxyurea: enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa

Realizing effectiveness across continents with hydroxyurea: enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa

Despite its well-described safety and efficacy in the treatment of sickle cell anemia (SCA) in high-income settings, hydroxyurea remains largely unavailable in sub-Saharan Africa, where more than 75% of annual SCA births occur and many comorbidities exist. Realizing Effectiveness Across Continents w...

Full description

Bibliographic Details
Main Authors: McGann, PT, Williams, TN, Olupot-Olupot, P, Tomlinson, GA, Lane, A, Luís Reis da Fonseca, J, Kitenge, R, Mochamah, G, Wabwire, H, Stuber, S, Howard, TA, McElhinney, K, Aygun, B, Latham, T, Santos, B, Tshilolo, L, Ware, RE
Other Authors: REACH Investigators
Format: Journal article
Language:English
Published: Wiley 2018

Similar Items